CASI Pharmaceuticals, Inc. (CASI)
After hours:
Chart Events
Performance Outlook
| Previous Close | 2.8600 |
| Open | 3.0700 |
| Bid | 2.8700 x 1000 |
| Ask | 2.9500 x 1300 |
| Day's Range | 2.8200 - 3.0700 |
| 52 Week Range | 2.6900 - 17.4000 |
| Volume | |
| Avg. Volume | 64,647 |
| Market Cap | 404.013M |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- MarketWatch
CASI Pharmaceuticals stock falls after reverse split takes effect
Shares of CASI Pharmaceuticals Inc. are actually falling in premarket trading Thursday, as a 1-for-10 reverse stock split took effect. While some quote services may still be showing a big gain for the Maryland-based biopharmaceutical company's stock, closed Wednesday at a pre-split price of 40.63 cents, meaning a 1-for-10 reverse split would adjust the price to $4.063. The stock is currently trading 15.6% below that split-adjusted price. On a pre-split basis, the stock has closed below $1 since
- Simply Wall St.
A CASI Pharmaceuticals, Inc. (NASDAQ:CASI) insider increased their holdings by 10% last year
Viewing insider transactions for CASI Pharmaceuticals, Inc.'s ( NASDAQ:CASI ) over the last year, we see that insiders...
- Zacks
CASI Pharmaceuticals, Inc. (CASI) Reports Q1 Loss, Misses Revenue Estimates
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
